-+ 0.00%
-+ 0.00%
-+ 0.00%

Cue Biopharma prices USD 50 million private placement of common stock at USD 33.21 per share

PUBT·07/10/2026 01:41:15
Listen to the news
Cue Biopharma prices USD 50 million private placement of common stock at USD 33.21 per share
  • Cue Biopharma priced a USD 50 million private placement of unregistered equity to accredited investors, with closing expected around July 13, 2026.
  • Deal includes 1,418,071 common shares at USD 33.21 each, plus pre-funded warrants for up to 87,500 shares at USD 33.21.
  • Pre-funded warrants carry a USD 0.001 exercise price, are immediately exercisable, remain outstanding until fully exercised.
  • Cormorant Asset Management led the financing; Columbia Threadneedle Investments participated among other new funds.
  • Proceeds earmarked for clinical development, general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607092140PRIMZONEFULLFEED9760193) on July 10, 2026, and is solely responsible for the information contained therein.